• 中国精品科技期刊
  • 《中文核心期刊要目总览》收录期刊
  • RCCSE 中国核心期刊(5/114,A+)
  • Scopus收录期刊
  • 美国《化学文摘》(CA)收录期刊
  • WHO 西太平洋地区医学索引(WPRIM)收录期刊
  • 《中国科学引文数据库(CSCD)》核心库期刊 (C)
  • 中国科技核心期刊
  • 中国科技论文统计源期刊
  • 《日本科学技术振兴机构数据库(中国)》(JSTChina)收录期刊
  • 美国《乌利希期刊指南》(UIrichsweb)收录期刊
  • 中华预防医学会系列杂志优秀期刊(2019年)

留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

2015—2023年上海市成人急性呼吸道感染病例中肺炎支原体感染特征

邱琪 时慧琳 刘嘉婧 姜晨彦 滕峥 吴寰宇 郑雅旭 陈健

邱琪, 时慧琳, 刘嘉婧, 姜晨彦, 滕峥, 吴寰宇, 郑雅旭, 陈健. 2015—2023年上海市成人急性呼吸道感染病例中肺炎支原体感染特征[J]. 中华疾病控制杂志, 2025, 29(3): 304-309. doi: 10.16462/j.cnki.zhjbkz.2025.03.009
引用本文: 邱琪, 时慧琳, 刘嘉婧, 姜晨彦, 滕峥, 吴寰宇, 郑雅旭, 陈健. 2015—2023年上海市成人急性呼吸道感染病例中肺炎支原体感染特征[J]. 中华疾病控制杂志, 2025, 29(3): 304-309. doi: 10.16462/j.cnki.zhjbkz.2025.03.009
QIU Qi, SHI Huilin, LIU Jiajing, JIANG Chenyan, TENG Zheng, WU Huanyu, ZHENG Yaxu, CHEN Jian. Characteristics of mycoplasma pneumoniae infection in acute respiratory tract infection adult cases in Shanghai, 2015-2023[J]. CHINESE JOURNAL OF DISEASE CONTROL & PREVENTION, 2025, 29(3): 304-309. doi: 10.16462/j.cnki.zhjbkz.2025.03.009
Citation: QIU Qi, SHI Huilin, LIU Jiajing, JIANG Chenyan, TENG Zheng, WU Huanyu, ZHENG Yaxu, CHEN Jian. Characteristics of mycoplasma pneumoniae infection in acute respiratory tract infection adult cases in Shanghai, 2015-2023[J]. CHINESE JOURNAL OF DISEASE CONTROL & PREVENTION, 2025, 29(3): 304-309. doi: 10.16462/j.cnki.zhjbkz.2025.03.009

2015—2023年上海市成人急性呼吸道感染病例中肺炎支原体感染特征

doi: 10.16462/j.cnki.zhjbkz.2025.03.009
邱琪和时慧琳为共同第一作者
基金项目: 

上海市加强公共卫生体系建设三年行动计划(2023—2025年)优秀人才培养计划 GWVI-11.2-YQ13

上海市公共卫生体系建设三年行动计划(2023-2025年)重点学科建设项目 GWVI-11.1-03

上海市科技重大专项 ZD2021CY001

上海市“医苑新星”青年医学人才培养资助计划公共卫生领导者项目 SHWSRS(2022)_065

详细信息
    通讯作者:

    陈健,E-mail: chenjian@scdc.sh.cn

    郑雅旭,E-mail: zhengyaxu@scdc.sh.cn

  • 中图分类号: R183.3

Characteristics of mycoplasma pneumoniae infection in acute respiratory tract infection adult cases in Shanghai, 2015-2023

QIU Qi and SHI Huilin contributed equally to this article
Funds: 

Outstanding Youth Training Program of Three-year Action Program of Shanghai Municipality for Strengthening the Construction of Public Health System (2023-2025) GWVI-11.2-YQ13

Key Discipline-Infectious Diseases of Three-year Action Program of Shanghai Municipality for Strengthening the Construction of Public Health System (2023-2025) GWVI-11.1-03

Shanghai Municipal Science and Technology Major Project ZD2021CY001

Shanghai "Rising Stars of Medical Talents" Youth Development Program, Youth Medical Talents-Public Health Leadership Program SHWSRS(2022)_065

More Information
  • 摘要:   目的  分析2015—2023年上海市成人急性呼吸道感染病例中肺炎支原体感染的流行特征和混合感染情况,为肺炎支原体防控提供科学依据。  方法  收集2015—2023年在上海市20所医院门(急)诊就诊和住院的成人急性呼吸道感染病例,采集其基本信息和咽拭子、痰液标本,利用多重聚合酶链式反应技术进行常见呼吸道病原体的核酸检测。通过描述性流行病学方法分析肺炎支原体的感染状况和流行特征。  结果  共纳入10 971例成人急性呼吸道感染病例,肺炎支原体总阳性率为1.87%(205/10 971),严重急性呼吸道感染(severe acute respiratory infection, SARI)病例(2.11%)的阳性率高于流行性感冒(简称流感)样病例(influenza-like illness, ILI)(1.52%)(χ2=4.68, P=0.030)。205例肺炎支原体阳性病例的发病时间主要在第4季度,占37.07%(76/205)。随着年龄的增长,肺炎支原体阳性率呈下降趋势(χ2=11.81, P<0.001),18~<46岁年龄组阳性率(4.12%)高于其他年龄组(0.63%~1.76%)。205例肺炎支原体阳性病例中,与其他呼吸道病原体混合感染占比为22.93%(47/205),ILI和SARI病例中混合感染占比分别为38.81%(26/67)和15.22%(21/138),主要为肺炎支原体与甲型流感病毒的混合感染。  结论  2015—2023年上海市成人急性呼吸道感染病例中,肺炎支原体感染以青壮年人群为主,需进一步加强流行季节成人肺炎支原体监测,重点关注与流感病毒等其他病原体的混合感染。
  • 图  1  2015—2023年上海市成年人急性呼吸道感染病例中肺炎支原体阳性病例时间分布

    ILI,流行性感冒样病例;SARI,严重急性呼吸道感染。

    Figure  1.  Temporal distribution of positive cases of Mycoplasma pneumoniae among adult acute respiratory infections in Shanghai from 2015 to 2023

    ILI, influenza-like illness; SARI, severe acute respiratory infection.

    表  1  2015—2023年上海市205例肺炎支原体阳性病例的基本信息和临床特征

    Table  1.   Basic information and clinical characteristics of 205 positive cases of Mycoplasma pneumoniae in Shanghai from 2015 to 2023

    变量
    Variable
    合计Total
    (n=205)
    流行性感冒样病例
    Influenza-like cases (n=67)
    严重急性呼吸道感染病例
    Severe acute respiratory infection cases (n=138)
    χ2值value P
    value
    性别Gender 1.50 0.220
      男Male 90(43.90) 34(50.75) 56(40.58)
      女Female 115(56.10) 33(49.25) 82(59.42)
    年龄组/岁Age group/years 12.85 0.002
      18~ < 46 138(67.32) 51(76.12) 87(63.04)
      46~60 30(14.63) 13(19.40) 17(12.32)
      >60 37(18.05) 3(4.48) 34(24.64)
    职业Occupation 53.57 <0.001
      职员Staff 52(25.37) 2(2.99) 50(36.23)
      退休人员Retired personnel 31(15.12) 1(1.49) 30(21.74)
      其他Others 122(59.51) 64(95.52) 58(42.03)
    发病时间/季度Onset/quarter 17.88 <0.001
      1 30(14.63) 19(28.36) 11(7.97)
      2 29(14.15) 7(10.44) 22(15.94)
      3 70(34.15) 15(22.39) 55(39.86)
      4 76(37.07) 26(38.81) 50(36.23)
    体温Body temperature/℃ 5.35 0.021
      38.0~ < 39.0 122(59.51) 48(71.64) 74(53.62)
      ≥39.0 83(40.49) 19(28.36) 64(46.38)
    临床症状Clinical symptoms
      咳嗽Cough 178(86.83) 56(83.58) 122(88.41) 0.54 0.461
      咽痛Sore throat 62(30.24) 30(44.78) 32(23.19) 8.97 0.003
      肌肉酸痛Muscle soreness 45(21.95) 25(37.31) 20(14.49) 12.41 <0.001
    采样前使用抗生素Antibiotics are used before sampling 20.69 <0.001
      是Yes 94(45.85) 15(22.39) 79(57.25)
      否No 111(54.15) 52(77.61) 59(42.75)
    标本类型Specimen type 13.51 <0.001
      咽拭子标本Throat swab specimens 173(84.39) 66(98.51) 107(77.54)
      痰液标本Sputum specimens 32(15.61) 1(1.49) 31(22.46)
    注:①以人数(占比/%)表示。
    Note: ① Number of people (proportion/%).
    下载: 导出CSV

    表  2  急性呼吸道感染病例中肺炎支原体阳性率(%)的影响因素

    Table  2.   Factors influencing the positive rate (%) of Mycoplasma pneumoniae in acute respiratory infection cases

    变量
    Variable
    合计
    Total
    流行性感冒样病例
    Influenza-like cases
    严重急性呼吸道感染病例
    Severe acute respiratory infection cases
    χ2
    value
    P
    value
    性别Gender 5.86 0.016
      男Male 1.57(90/5 734) 1.63(34/2 090) 1.54(56/3 644)
      女Female 2.20(115/5 237) 1.42(33/2 328) 2.82(82/2 909)
    年龄组/岁Age group/years 142.35 <0.001
      18~46 4.12(138/3 352) 2.12(51/2 400) 9.14(87/952) 140.74 <0.001
      46~60 1.76(30/1 705) 1.56(13/833) 1.95(17/872) 19.52 <0.001
      >60 0.63(37/5 914) 0.25(3/1 185) 0.72(34/4 729)
    职业Occupation 58.14 <0.001
      职员Staff 2.35(52/2 210) 0.15(2/1 324) 5.64(50/886) 33.00 <0.001
      退休人员Retired personnel 0.70(31/4 456) 0.14(1/714) 0.80(30/3 742)
      其他Others 2.83(122/4 305) 2.69(64/2 380) 3.01(58/1 925) 58.34 <0.001
    发病时间/季度Onset/quarter 26.72 <0.001
      1 1.09(30/2 759) 1.68(19/1 129) 0.67(11/1 630)
      2 1.28(29/2 266) 0.82(7/858) 1.56(22/1 408) 0.40 0.529
      3 2.22(70/3 157) 1.04(15/1 437) 3.20(55/1 720) 11.31 0.001
      4 2.72(76/2 789) 2.62(26/994) 2.79(50/1 795) 19.85 <0.001
    体温Body temperature/℃ 33.05 <0.001
      38.0~<39.0 1.46(122/8 382) 1.36(48/3 526) 1.52(74/4 856)
      ≥39.0 3.21(83/2 589) 2.13(19/892) 3.77(64/1 697)
    临床症状Clinical symptoms
      咳嗽Cough 2.25(178/7 919) 2.13(56/2 634) 2.31(122/5 285) 22.32 <0.001
      咽痛Sore throat 1.29(62/4 810) 1.10(30/2 723) 1.53(32/2 087) 15.69 <0.001
      全身酸痛Muscle soreness 2.09(45/2 148) 1.85(25/1 352) 2.51(20/796) 0.75 0.388
    采样前使用抗生素Antibiotics are used before sampling 27.30 <0.001
      是Yes 2.92(94/3 224) 2.59(15/579) 2.99(79/2 645)
      否No 1.43(111/7 747) 1.35(52/3 839) 1.51(59/3 908)
    标本类型Specimen type 13.94 <0.001
      咽拭子标本Throat swab specimens 1.72(173/10 046) 1.50(66/4 395) 1.89(107/5 651)
      痰液标本Sputum specimens 3.46(32/925) 4.35(1/23) 3.44(31/902)
    注:①表示与该组比较。
    Note: ① Indicates comparison with this group.
    下载: 导出CSV

    表  3  47例肺炎支原体阳性病例的混合感染情况

    Table  3.   Mixed infections in 47 Mycoplasma pneumoniae infection among influenza-like cases and severe acute respiratory infection

    混合感染Co-infection 合计Total
    (n=47)
    流行性感冒样病例
    Influenza-like cases
    严重急性呼吸道感染病例
    Severe acute respiratory infection cases
    肺炎支原体+甲型流感病毒Mycoplasma pneumoniae + influenza A virus 39(82.96) 20(76.90) 19(90.48)
    肺炎支原体+副流感病毒Mycoplasma pneumoniae + parainfluenza virus 1(2.13) 1(3.85) 0(0)
    肺炎支原体+人偏肺病毒Mycoplasma pneumoniae + human metapneumovirus 1(2.13) 1(3.85) 0(0)
    肺炎支原体+乙型流感病毒Mycoplasma pneumoniae + influenza B virus 1(2.13) 0(0) 1(4.76)
    肺炎支原体+冠状病毒Mycoplasma pneumoniae + coronavirus 1(2.13) 0(0) 1(4.76)
    肺炎支原体+甲型流感病毒+博卡病毒Mycoplasma pneumoniae + influenza A virus + bocavirus 1(2.13) 1(3.85) 0(0)
    肺炎支原体+甲型流感病毒+冠状病毒Mycoplasma pneumoniae + influenza A virus + coronavirus 1(2.13) 1(3.85) 0(0)
    肺炎支原体+人偏肺病毒+鼻病毒/肠道病毒Mycoplasma pneumoniae + human metapneumovirus + rhinovirus/enterovirus 1(2.13) 1(3.85) 0(0)
    肺炎支原体+甲型流感病毒+博卡病毒+副流感病毒+人偏肺病毒
    Mycoplasma pneumoniae + influenza A virus + bocavirus + parainfluenza virus + human metapneumovirus
    1(2.13) 1(3.85) 0(0)
    合计Total 47(100.00) 26(55.32) 21(44.68)
    注:①以人数(占比/%)表示。
    Note: ① Number of people (proportion/%).
    下载: 导出CSV
  • [1] Waites KB, Xiao L, Liu Y, et al. Mycoplasma pneumoniae from the respiratory tract and beyond[J]. Clin Microbiol Rev, 2017, 30(3): 747-809. DOI: 10.1128/CMR.00114-16.
    [2] 孙国磊, 王一民. 肺炎支原体感染诊断方法的研究进展[J]. 医学综述, 2021, 27(10): 1961-1965. DOI: 10.3969/j.issn.1006-2084.2021.10.016.

    Sun GL, Wang YM. Research progress of diagnosis methods of Mycoplasma pneumoniae infection[J]. Medical Recapitulate, 2021, 27(10): 1961-1965. DOI: 10.3969/j.issn.1006-2084.2021.10.016.
    [3] WHO. WHO surveillance case definitions for ILI and SARI[EB/OL] (2024-11-20). https://wwwwhoint/teams/global-influenza-programme/surveillance-and-monitoring/case-definitions-for-ili-and-sari 2014.
    [4] Salez N, Vabret A, Leruez-Ville M, et al. Evaluation of four commercial multiplex molecular tests for the diagnosis of acute respiratory infections[J]. PLoS One, 2015, 10(6): e0130378. DOI: 10.1371/journal.pone.0130378.
    [5] Si YJ, Zhao ZZ, Chen R, et al. Epidemiological surveillance of common respiratory viruses in patients with suspected COVID-19 in Southwest China[J]. BMC Infect Dis, 2020, 20(1): 688. DOI: 10.1186/s12879-020-05392-x.
    [6] 卢瑞萍, 朱丽. 西安市2021—2023年成人肺炎支原体感染情况及影响因素[J]. 中国国境卫生检疫杂志, 2023, 46(6): 598-601. DOI: 10.16408/j.1004-9770.2023.06.022.

    Lu RP, Zhu L. Infection status and influencing factors of Mycoplasma pneumoniae in adults in Xi 'an from 2021 to 2023[J]. Chinese Journal of Frontier Health Quarantine, 2023, 46(6): 598-601. DOI: 10.16408/j.1004-9770.2023.06.022.
    [7] 钱莉. 南京市浦口区不同人群肺炎支原体感染的流行病学调查分析[D]. 南京: 南京医科大学, 2019.

    Qian L. Epidemiological investigation and analysis of mycoplasma pneumoniae infection in different populations in Pukou District of Nanjing[D]. Nanjing: Nanjing Medical University, 2019.
    [8] 史云菊, 柳璐, 李肖静, 等. 呼吸道感染肺炎支原体调查与季节因素的相关性研究[J]. 中华医院感染学杂志, 2016, 26(14): 3216-32188. DOI: 10.11816/cn.ni.2016-153765.

    Shi YJ, Liu L, Li XJ, et al. Respi ratory tract infection pneumonia mycoplasma survey and its correlation with seasonal factor[J]. Chin J Nosocomiology, 2016, 26(14): 3216-3218. DOI: 10.11816/cn.ni.2016-153765.
    [9] 王军华, 范承武, 刘胜, 等. 桂林市儿童肺炎支原体感染流行特点及与气候因素相关性研究[J]. 临床儿科杂志, 2013, 31(11): 1038-1041. DOI: 10.3969j.issn.1000-3606.2013.11.009.

    Wang JH, Fan CW, Liu S, et al. Epidemiological characteristics and meteorological factors in childhood Mycoplasma pneumoniae infection in Guilin[J]. J Clin Pediatr, 2013, 31(11): 1038-1041. DOI: 10.3969/j.issn.1000-3606.2013.11.009.
    [10] Li ZJ, Zhang HY, Ren LL, et al. Etiological and epidemiological features of acute respiratory infections in China[J]. Nat Commun, 2021, 12(1): 5026. DOI: 10.1038/s41467-021-25120-6.
    [11] Yan C, Xue GH, Zhao HQ, et al. Current status of Mycoplasma pneumoniae infection in China[J]. World J Pediatr 2024, 20(1): 1-4. DOI: 10.1007/s12519-023-00783-x.
    [12] 朱祥. 肺炎支原体感染的研究进展[J]. 实用心脑肺血管病杂志, 2020, 28(2): 107-112. DOI: 10.3969/j.issn.1008-5971.2020.01.y05.

    Zhu X. Research progress on Mycoplasma pneumoniae infection[J]. Pract J Card Cereb Pneumal Vasc Dis, 2020, 28(2): 107-112. DOI: 10.3969/j.issn.1008-5971.2020.01.y05.
    [13] Li H, Li SK, Yang HJ, et al. Resurgence of Mycoplasma pneumonia by macrolide-resistant epidemic clones in China[J]. Lancet Microbe, 2024, 5(6): e515. DOI: 10.1016/S2666-5247(23)00405-6.
    [14] 刘馨玉, 李萌, 陈明伟, 等. 成人社区获得性肺炎住院患者的病原学分析[J]. 临床医学研究与实践, 2019, 4(29): 20-21. DOI: 10.19347/j.cnki.2096-1413.201929010.

    Liu XY, Li M, Chen MW, et al. Etiological analysis of adult inpatients with community-acquired pneumonia[J]. Clin Res Pract, 2019, 4(29): 20-21. DOI: 10.19347/j.cnki.2096-1413.201929010.
    [15] Larcher C, Jeller V, Fischer H, et al. Prevalence of respiratory viruses, including newly identified viruses, in hospitalised children in Austria[J]. Eur J Clin Microbiol Infect Dis, 2006, 25(11): 681-686. DOI: 10.1007/s10096-006-0214-z.
    [16] Kim D, Quinn J, Pinsky B, et al. Rates of co-infection between SARS-CoV-2 and other respiratory pathogens[J]. JAMA, 2020, 323(20): 2085-2086. DOI: 10.1001/jama.2020.6266.
    [17] Opatowski L, Baguelin M, Eggo RM. Influenza interaction with cocirculating pathogens and its impact on surveillance, pathogenesis, and epidemic profile: a key role for mathematical modelling[J]. PLoS Pathog, 2018, 14(2): e1006770. DOI: 10.1371/journal.ppat.1006770.
    [18] Jacoby P, Watson K, Bowman J, et al. Modelling the co-occurrence of Streptococcus pneumoniae with other bacterial and viral pathogens in the upper respiratory tract[J]. Vaccine, 2007, 25(13): 2458-2464. DOI: 10.1016/j.vaccine.2006.09.020.
  • 加载中
图(1) / 表(3)
计量
  • 文章访问数:  38
  • HTML全文浏览量:  17
  • PDF下载量:  7
  • 被引次数: 0
出版历程
  • 收稿日期:  2024-08-12
  • 修回日期:  2024-11-11
  • 网络出版日期:  2025-04-11
  • 刊出日期:  2025-03-10

目录

    /

    返回文章
    返回